An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children

Condition:   InfluenzaInterventions:   Biological: Influenza vaccine GSK2321138A;   Biological: Havrix Junior;   Biological: Prevenar 13;   Biological: Varivax/ProVarivax;   Biological: VarilrixSponsor:   GlaxoSmithKlineCompleted - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials